approval
saveVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalCARIPRAZINE HYDROCHLORIDE — FDA approvalDec 16, 2025 · 292d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 22, 2024 · 681d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 16, 2022 · 1388d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalMay 24, 2019 · 2690d ago
same company · ±60 days · 6
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalSep 17, 2015
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalSep 23, 2015
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalSep 23, 2015
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalSep 23, 2015
- approvaladalimumab: HUMIRA (ADALIMUMAB) — FDA approvalSep 9, 2015
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalAug 24, 2015
comments(0)
5-min edit window · permanent after that